Oxford Biomedica Plc New (OXBDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,629 | 129,012 | 174,755 | 149,809 | 60,018 |
| Receivables | 63,813 | 30,775 | 76,157 | 62,299 | 69,403 |
| Inventories | 14,687 | 16,012 | 15,616 | 13,092 | 8,875 |
| Other current assets | 0 | 0 | 28 | 102 | 307 |
| TOTAL | $144,129 | $175,799 | $266,557 | $225,302 | $138,603 |
| Non-Current Assets | |||||
| PPE Net | 69,575 | 94,153 | 165,473 | 95,883 | 92,838 |
| Intangibles | 31,618 | 38,537 | 130,970 | 72 | 94 |
| Other Non-Current Assets | 5,339 | 5,399 | 6,197 | 4,957 | 4,629 |
| TOTAL | $106,532 | $138,089 | $302,640 | $100,912 | $97,561 |
| Total Assets | $250,661 | $313,888 | $569,197 | $326,214 | $236,164 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 304 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 28,318 | 22,144 | 45,245 | 26,207 | 25,315 |
| Other current liabilities | 29,401 | 26,866 | 22,722 | 17,192 | 34,999 |
| TOTAL | $63,109 | $55,123 | $73,797 | $45,801 | $67,352 |
| Non-Current Liabilities | |||||
| Long Term Debt | 43,057 | 47,932 | 49,204 | N/A | N/A |
| Deferred Revenues | 608 | 639 | 1,106 | 1,229 | 1,292 |
| Other Non-Current Liabilities | 13,952 | 59,986 | 65,165 | 8,713 | 8,785 |
| TOTAL | $122,099 | $161,947 | $203,254 | $22,805 | $24,046 |
| Total Liabilities | $185,208 | $217,071 | $277,051 | $68,605 | $91,398 |
| Shareholders' Equity | |||||
| Common Shares | 57,331 | 60,209 | 59,535 | 59,250 | 52,851 |
| Retained earnings | -432,299 | -438,995 | -245,580 | -228,000 | -242,320 |
| Other shareholders' equity | 13,148 | 2,508 | 8,228 | 3,150 | 2,942 |
| TOTAL | $65,453 | $96,818 | $292,146 | $257,609 | $144,766 |
| Total Liabilities And Equity | $250,661 | $313,888 | $569,197 | $326,214 | $236,164 |